PLCL1 Antikörper (AA 110-350)

Produktnummer ABIN7269343

Produktdetails anti-PLCL1 Antikörper

Target: PLCL1 (phospholipase C-Like 1 (PLCL1))

Bindungsspezifität: AA 110-350

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLCL1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Verwendungszweck: PLCL1 Rabbit pAb

Sequenz: DCISFMQAGC ELKKVRPNSR IYNRFFTLDT DLQALRWEPS KKDLEKAKLD ISAIKEIRLG KNTETFRNNG LADQICEDCA FSILHGENYE SLDLVANSAD VANIWVSGLR YLVSRSKQPL DFMEGNQNTP RFMWLKTVFE AADVDGNGIM LEDTSVELIK QLNPTLKEAK IRLKFKEIQK SKEKLTTRVT EEEFCEAFCE LCTRPEVYFL LVQISKNKEY LDANDLMLFL EAEQGVTHIT E

Kreuzreaktivität: Maus, Ratte

Produktmerkmale: Polyclonal Antibodies

Aufreinigung: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 110-350 of human PLCL1 (NP_006217.3).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:200 - 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu PLCL1

Target: PLCL1 (phospholipase C-Like 1 (PLCL1))

Andere Bezeichnung: PLCL1 (PLCL1 Produkte)

Synonyme: PLCE antikoerper, PLCL antikoerper, PLDL1 antikoerper, PRIP antikoerper, C230017K02Rik antikoerper, PLC-L antikoerper, PLC-L1 antikoerper, PRIP-1 antikoerper, phospholipase C like 1 (inactive) antikoerper, phospholipase C-like 1 antikoerper, PLCL1 antikoerper, Plcl1 antikoerper

Hintergrund: Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity. Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C.,PLCL1,PLCE,PLCL,PLDL1,PPP1R127,PRIP,Signal Transduction,PLCL1

Molekulargewicht: 113kDa/122kDa

Gen-ID: 5334

UniProt: Q15111